Product NDC: | 0088-1097 |
Proprietary Name: | ALLEGRA |
Non Proprietary Name: | fexofenadine hydrochloride |
Active Ingredient(s): | 6 mg/mL & nbsp; fexofenadine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0088-1097 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021963 |
Marketing Category: | NDA |
Start Marketing Date: | 20061016 |
Package NDC: | 0088-1097-20 |
Package Description: | 300 mL in 1 BOTTLE (0088-1097-20) |
NDC Code | 0088-1097-20 |
Proprietary Name | ALLEGRA |
Package Description | 300 mL in 1 BOTTLE (0088-1097-20) |
Product NDC | 0088-1097 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fexofenadine hydrochloride |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20061016 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | FEXOFENADINE HYDROCHLORIDE |
Strength Number | 6 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |